VERU - Got $1500? Buy These 2 Surging Growth Stocks
In today's bearish market, consistent growth is hard to come by, but it still exists. Even with inflation and threats of recession, a few companies have so many positive milestones coming up that their share prices keep rising even as the market falls or moves sideways.
For investors looking to put $1,500 to work somewhere that it could grow over the next few years, two biotechs look particularly appealing. Their shares are likely to keep outperforming the market in the near-term, and their acumen with drug development might make them ripe for a long-term hold too.
With its shares up over 142% so far this year, it's a safe bet to call Veru (NASDAQ: VERU) a growth stock that's on a tear . Given that its quarterly revenue has only grown by 10% in the last three years, however, it's reasonable for investors to wonder what's so great about this biotech.
For further details see:
Got $1,500? Buy These 2 Surging Growth Stocks